Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro
- 1 August 2007
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 81 (10), 832-840
- https://doi.org/10.1016/j.lfs.2007.07.015
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Reactive oxygen species mediate RANK signaling in osteoclastsExperimental Cell Research, 2004
- Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza BungeBiochemical Pharmacology, 2004
- Androgens Suppress Osteoclast Formation Induced by RANKL and Macrophage-Colony Stimulating FactorEndocrinology, 2001
- Skeletal Unloading Induces Biphasic Changes in Insulin-Like Growth Factor-I mRNA Levels and Osteoblast ActivityExperimental Cell Research, 1999
- 1Phytoestrogens and boneBailliere's Clinical Endocrinology and Metabolism, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997
- Osteoblast and chondroblast differentiationBone, 1995
- [36] Flavonoids as antioxidants: Determination of radical-scavenging efficienciesMethods in enzymology, 1990
- Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat boneJournal of Cellular Physiology, 1987